# Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease

> **NCT01418794** · PHASE4 · UNKNOWN · sponsor: **Shenyang Northern Hospital** · enrollment: 606 (estimated)

## Conditions studied

- Acute Coronary Syndromes

## Interventions

- **DEVICE:** High dose rapamycin stent
- **DEVICE:** Low dose rapamycin stent

## Key facts

- **NCT ID:** NCT01418794
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2011-11
- **Final completion:** —
- **Target enrollment:** 606 (ESTIMATED)
- **Last updated:** 2011-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01418794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01418794, "Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01418794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*